{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T08:21:18Z","timestamp":1793521278429,"version":"4.5.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2017,10,25]],"date-time":"2017-10-25T00:00:00Z","timestamp":1508889600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1007\/s00125-017-4463-4","type":"journal-article","created":{"date-parts":[[2017,10,16]],"date-time":"2017-10-16T07:55:46Z","timestamp":1508140546000},"page":"2319-2328","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":70,"title":["Improving the clinical value and utility of CGM systems: issues and recommendations"],"prefix":"10.1007","volume":"60","author":[{"given":"John R.","family":"Petrie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne L.","family":"Peters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard M.","family":"Bergenstal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinhard W.","family":"Holl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. Alexander","family":"Fleming","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lutz","family":"Heinemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,10,25]]},"reference":[{"key":"4463_CR1","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1177\/1932296815603528","volume":"9","author":"L Heinemann","year":"2015","unstructured":"Heinemann L, Freckmann G (2015) CGM versus FGM; or, continuous glucose monitoring is not flash glucose monitoring. J Diabetes Sci Technol 9:947\u2013950","journal-title":"J Diabetes Sci Technol"},{"key":"4463_CR2","doi-asserted-by":"crossref","first-page":"63","DOI":"10.2337\/dc16-1525","volume":"40","author":"J Kropff","year":"2017","unstructured":"Kropff J, Choudhary P, Neupane S et al (2017) Accuracy and longevity of an implantable continuous glucose sensor in the PRECISE study: a 180-day, prospective, multicenter, pivotal trial. Diabetes Care 40:63\u201368","journal-title":"Diabetes Care"},{"key":"4463_CR3","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1007\/s00125-015-3513-z","volume":"58","author":"L Heinemann","year":"2015","unstructured":"Heinemann L, Fleming GA, Petrie JR, Holl RW, Bergenstal RM, Peters AL (2015) Insulin pump risks and benefits: a clinical appraisal of pump safety standards, adverse event reporting and research needs. A joint statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working Group. Diabetologia 58:862\u2013870","journal-title":"Diabetologia"},{"key":"4463_CR4","doi-asserted-by":"crossref","first-page":"231","DOI":"10.4158\/EP151124.CS","volume":"22","author":"TS Bailey","year":"2016","unstructured":"Bailey TS, Grunberger G, Bode BW et al (2016) American Association of Clinical Endocrinologists and American College of Endocrinology 2016 outpatient glucose monitoring consensus statement. Endocr Pract 22:231\u2013261","journal-title":"Endocr Pract"},{"key":"4463_CR5","doi-asserted-by":"crossref","first-page":"2968","DOI":"10.1210\/jc.2010-2756","volume":"96","author":"DC Klonoff","year":"2011","unstructured":"Klonoff DC, Buckingham B, Christiansen JS et al (2011) Continuous glucose monitoring: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 96:2968\u20132979","journal-title":"J Clin Endocrinol Metab"},{"key":"4463_CR6","doi-asserted-by":"crossref","first-page":"3922","DOI":"10.1210\/jc.2016-2534","volume":"101","author":"AL Peters","year":"2016","unstructured":"Peters AL, Ahmann AJ, Battelino T et al (2016) Diabetes technology-continuous subcutaneous insulin infusion therapy and continuous glucose monitoring in adults: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 101:3922\u20133937","journal-title":"J Clin Endocrinol Metab"},{"key":"4463_CR7","doi-asserted-by":"crossref","unstructured":"Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group (2008) Continuous glucose monitoring and intensive treatment of type 1 diabetes. N Engl J Med 359:1464\u20131476","DOI":"10.1056\/NEJMoa0805017"},{"key":"4463_CR8","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1001\/jama.2016.19975","volume":"317","author":"RW Beck","year":"2017","unstructured":"Beck RW, Riddlesworth T, Ruedy K et al (2017) Effect of continuous glucose monitoring on glycemic control in adults with type 1 diabetes using insulin injections: the DIAMOND randomized clinical trial. JAMA 317:371\u2013378","journal-title":"JAMA"},{"key":"4463_CR9","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1177\/1932296816642578","volume":"10","author":"M Lind","year":"2016","unstructured":"Lind M, Polonsky W, Hirsch IB et al (2016) Design and methods of a randomized trial of continuous glucose monitoring in persons with type 1 diabetes with impaired glycemic control treated with multiple daily insulin injections (GOLD Study). J Diabetes Sci Technol 10:754\u2013761","journal-title":"J Diabetes Sci Technol"},{"key":"4463_CR10","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.2337\/dc14-0303","volume":"37","author":"JC Wong","year":"2014","unstructured":"Wong JC, Foster NC, Maahs DM et al (2014) Real-time continuous glucose monitoring among participants in the T1D Exchange clinic registry. Diabetes Care 37:2702\u20132709","journal-title":"Diabetes Care"},{"key":"4463_CR11","doi-asserted-by":"crossref","first-page":"538","DOI":"10.2337\/dc16-2482","volume":"40","author":"G Aleppo","year":"2017","unstructured":"Aleppo G, Ruedy KJ, Riddlesworth TD et al (2017) REPLACE-BG: a randomized trial comparing continuous glucose monitoring with and without routine blood glucose monitoring in adults with well-controlled type 1 diabetes. Diabetes Care 40:538\u2013545","journal-title":"Diabetes Care"},{"key":"4463_CR12","unstructured":"US Food and Drug Administration (2016) FDA expands indication for continuous glucose monitoring system, first to replace fingerstick testing for diabetes treatment decisions. Available from \nwww.fda.gov\/NewsEvents\/Newsroom\/PressAnnouncements\/ucm534056.htm\n\n. Accessed 21 April 2017"},{"key":"4463_CR13","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1016\/S0140-6736(16)31535-5","volume":"388","author":"J Bolinder","year":"2016","unstructured":"Bolinder J, Antuna R, Geelhoed-Duijvestijn P, Kr\u00f6ger J, Weitgasser R (2016) Novel glucose-sensing technology and hypoglycaemia in type 1 diabetes: a multicentre, non-masked, randomised controlled trial. Lancet 388:2254\u20132263","journal-title":"Lancet"},{"key":"4463_CR14","doi-asserted-by":"crossref","first-page":"32","DOI":"10.2337\/dc11-1438","volume":"35","author":"RA Vigersky","year":"2012","unstructured":"Vigersky RA, Fonda SJ, Chellappa M, Walker MS, Ehrhardt NM (2012) Short- and long-term effects of real-time continuous glucose monitoring in patients with type 2 diabetes. Diabetes Care 35:32\u201338","journal-title":"Diabetes Care"},{"key":"4463_CR15","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1177\/193229681100500320","volume":"5","author":"NM Ehrhardt","year":"2011","unstructured":"Ehrhardt NM, Chellappa M, Walker MS, Fonda SJ, Vigersky RA (2011) The effect of real-time continuous glucose monitoring on glycemic control in patients with type 2 diabetes mellitus. J Diabetes Sci Technol 5:668\u2013675","journal-title":"J Diabetes Sci Technol"},{"key":"4463_CR16","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.diabres.2008.06.015","volume":"82","author":"HJ Yoo","year":"2008","unstructured":"Yoo HJ, An HG, Park SY et al (2008) Use of a real time continuous glucose monitoring system as a motivational device for poorly controlled type 2 diabetes. Diabetes Res Clin Pract 82:73\u201379","journal-title":"Diabetes Res Clin Pract"},{"key":"4463_CR17","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s13300-016-0223-6","volume":"8","author":"T Haak","year":"2017","unstructured":"Haak T, Hanaire H, Ajjan R, Hermanns N, Riveline JP, Rayman G (2017) Flash glucose-sensing technology as a replacement for blood glucose monitoring for the management of insulin-treated type 2 diabetes: a multicenter, open-label randomized controlled trial. Diabetes Ther 8:55\u201373","journal-title":"Diabetes Ther"},{"key":"4463_CR18","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S2213-8587(16)30193-0","volume":"4","author":"CA Beers van","year":"2016","unstructured":"van Beers CA, DeVries JH, Kleijer SJ et al (2016) Continuous glucose monitoring for patients with type 1 diabetes and impaired awareness of hypoglycaemia (IN CONTROL): a randomised, open-label, crossover trial. Lancet Diabetes Endocrinol 4:893\u2013902","journal-title":"Lancet Diabetes Endocrinol"},{"key":"4463_CR19","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1089\/dia.2015.0394","volume":"18","author":"N Taleb","year":"2016","unstructured":"Taleb N, Emami A, Suppere C et al (2016) Comparison of two continuous glucose monitoring systems, Dexcom G4 Platinum and Medtronic Paradigm Veo Enlite system, at rest and during exercise. Diabetes Technol Ther 18:561\u2013567","journal-title":"Diabetes Technol Ther"},{"key":"4463_CR20","doi-asserted-by":"publisher","unstructured":"Agiostratidou G, Anhalt H, Ball D et al (2017) Standardizing clinically meaningful outcome measures beyond HbA1c for type 1 diabetes: a consensus report of the American Association of Clinical Endocrinologists, the American Association of Diabetes Educators, the American Diabetes Association, the Endocrine Society, JDRF International, the Leona M. and Harry B. Helmsley Charitable Trust, the Pediatric Endocrine Society, and the T1D Exchange. Diabetes Care \nhttps:\/\/doi.org\/10.2337\/dc17-1624","DOI":"10.2337\/dc17-1624"},{"key":"4463_CR21","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.2337\/dc15-2716","volume":"39","author":"DM Maahs","year":"2016","unstructured":"Maahs DM, Buckingham BA, Castle JR et al (2016) Outcome measures for artificial pancreas clinical trials: a consensus report. Diabetes Care 39:1175\u20131179","journal-title":"Diabetes Care"},{"key":"4463_CR22","doi-asserted-by":"crossref","first-page":"e70","DOI":"10.2337\/dc14-3044","volume":"38","author":"KD Barnard","year":"2015","unstructured":"Barnard KD, Kubiak T, Hermanns N, Heinemann L (2015) Patient-reported outcomes and continuous glucose monitoring: can we do better with artificial pancreas devices? Diabetes Care 38:e70","journal-title":"Diabetes Care"},{"key":"4463_CR23","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1177\/1932296816643542","volume":"10","author":"WH Polonsky","year":"2016","unstructured":"Polonsky WH, Peters AL, Hessler D (2016) The impact of real-time continuous glucose monitoring in patients 65 years and older. J Diabetes Sci Technol 10:892\u2013897","journal-title":"J Diabetes Sci Technol"},{"key":"4463_CR24","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.jclinepi.2013.08.015","volume":"67","author":"J McCambridge","year":"2014","unstructured":"McCambridge J, Witton J, Elbourne DR (2014) Systematic review of the Hawthorne effect: new concepts are needed to study research participation effects. J Clin Epidemiol 67:267\u2013277","journal-title":"J Clin Epidemiol"},{"key":"4463_CR25","doi-asserted-by":"publisher","unstructured":"Langendam M, Luijf YM, Hooft L, Devries JH, Mudde AH, Scholten RJ. (2012) Continuous glucose monitoring systems for type 1 diabetes mellitus. Cochrane Database Syst Rev, Issue 1, Art. no.:CD008101. doi: \nhttps:\/\/doi.org\/10.1002\/14651858.CD008101.pub2","DOI":"10.1002\/14651858.CD008101.pub2"},{"key":"4463_CR26","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1177\/193229681100500419","volume":"5","author":"GY Gandhi","year":"2011","unstructured":"Gandhi GY, Kovalaske M, Kudva Y et al (2011) Efficacy of continuous glucose monitoring in improving glycemic control and reducing hypoglycemia: a systematic review and meta-analysis of randomized trials. J Diabetes Sci Technol 5:952\u2013965","journal-title":"J Diabetes Sci Technol"},{"key":"4463_CR27","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s00125-007-0884-9","volume":"51","author":"DT Golicki","year":"2008","unstructured":"Golicki DT, Golicka D, Groele L, Pankowska E (2008) Continuous glucose monitoring system in children with type 1 diabetes mellitus: a systematic review and meta-analysis. Diabetologia 51:233\u2013240","journal-title":"Diabetologia"},{"key":"4463_CR28","doi-asserted-by":"crossref","first-page":"d3805","DOI":"10.1136\/bmj.d3805","volume":"343","author":"JC Pickup","year":"2011","unstructured":"Pickup JC, Freeman SC, Sutton AJ (2011) Glycaemic control in type 1 diabetes during real time continuous glucose monitoring compared with self monitoring of blood glucose: meta-analysis of randomised controlled trials using individual patient data. BMJ 343:d3805","journal-title":"BMJ"},{"key":"4463_CR29","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1758-5996-5-39","volume":"5","author":"N Poolsup","year":"2013","unstructured":"Poolsup N, Suksomboon N, Kyaw AM (2013) Systematic review and meta-analysis of the effectiveness of continuous glucose monitoring (CGM) on glucose control in diabetes. Diabetol Metab Syndr 5:39","journal-title":"Diabetol Metab Syndr"},{"key":"4463_CR30","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1177\/193229681200600513","volume":"6","author":"B Floyd","year":"2012","unstructured":"Floyd B, Chandra P, Hall S et al (2012) Comparative analysis of the efficacy of continuous glucose monitoring and self-monitoring of blood glucose in type 1 diabetes mellitus. J Diabetes Sci Technol 6:1094\u20131102","journal-title":"J Diabetes Sci Technol"},{"key":"4463_CR31","unstructured":"Golden SH, Brown T, Yeh H-C, et al. (2012) Methods for insulin delivery and glucose monitoring: comparative effectiveness. Rockville, MD, US Agency for Healthcare Research and Quality. Available from \nwww.ncbi.nlm.nih.gov\/pubmed\/22876370\n\n. Accessed 21 Sept 2017"},{"key":"4463_CR32","doi-asserted-by":"crossref","first-page":"336","DOI":"10.7326\/0003-4819-157-5-201209040-00508","volume":"157","author":"HC Yeh","year":"2012","unstructured":"Yeh HC, Brown TT, Maruthur N et al (2012) Comparative effectiveness and safety of methods of insulin delivery and glucose monitoring for diabetes mellitus: a systematic review and meta-analysis. Ann Intern Med 157:336\u2013347","journal-title":"Ann Intern Med"},{"key":"4463_CR33","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1177\/193229681300700617","volume":"7","author":"JC Pickup","year":"2013","unstructured":"Pickup JC (2013) The evidence base for diabetes technology: appropriate and inappropriate meta-analysis. J Diabetes Sci Technol 7:1567\u20131574","journal-title":"J Diabetes Sci Technol"},{"key":"4463_CR34","unstructured":"U.S. Department of Health and Human Services (2016) Applying human factors and usability engineering to medical devices: guidance for industry and Food and Drug Administration staff. Available from \nwww.fda.gov\/downloads\/MedicalDevices\/...\/UCM259760.pdf\n\n. Accessed 27 Mar 2017"},{"key":"4463_CR35","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1001\/jama.2013.277818","volume":"310","author":"TT Ly","year":"2013","unstructured":"Ly TT, Nicholas JA, Retterath A, Lim EM, Davis EA, Jones TW (2013) Effect of sensor-augmented insulin pump therapy and automated insulin suspension vs standard insulin pump therapy on hypoglycemia in patients with type 1 diabetes: a randomized clinical trial. JAMA 310:1240\u20131247","journal-title":"JAMA"},{"key":"4463_CR36","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1056\/NEJMoa1303576","volume":"369","author":"RM Bergenstal","year":"2013","unstructured":"Bergenstal RM, Klonoff DC, Garg SK et al (2013) Threshold-based insulin-pump interruption for reduction of hypoglycemia. N Engl J Med 369:224\u2013232","journal-title":"N Engl J Med"},{"key":"4463_CR37","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1177\/1932296815597918","volume":"10","author":"L Heinemann","year":"2015","unstructured":"Heinemann L, Hermanns N (2015) IQWiG reanalyzes and raises questions about an article by Ly et al which concluded low glucose suspend is very beneficial. J Diabetes Sci Technol 10:185\u2013190","journal-title":"J Diabetes Sci Technol"},{"key":"4463_CR38","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.2337\/dc15-2468","volume":"39","author":"SM Anderson","year":"2016","unstructured":"Anderson SM, Raghinaru D, Pinsker JE et al (2016) Multinational home use of closed-loop control is safe and effective. Diabetes Care 39:1143\u20131150","journal-title":"Diabetes Care"},{"key":"4463_CR39","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1001\/jama.2016.11708","volume":"316","author":"RM Bergenstal","year":"2016","unstructured":"Bergenstal RM, Garg S, Weinzimer SA et al (2016) Safety of a hybrid closed-loop insulin delivery system in patients with type 1 diabetes. JAMA 316:1407\u20131408","journal-title":"JAMA"},{"key":"4463_CR40","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.2337\/diacare.26.8.2405","volume":"26","author":"E Kulcu","year":"2003","unstructured":"Kulcu E, Tamada JA, Reach G, Potts RO, Lesho MJ (2003) Physiological differences between interstitial glucose and blood glucose measured in human subjects. Diabetes Care 26:2405\u20132409","journal-title":"Diabetes Care"},{"key":"4463_CR41","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1177\/1932296817699637","volume":"11","author":"T Siegmund","year":"2017","unstructured":"Siegmund T, Heinemann L, Kolassa R, Thomas A (2017) Discrepancies between blood glucose and interstitial glucose-technological artifacts or physiology: implications for selection of the appropriate therapeutic target. J Diabetes Sci Technol 11:766\u2013772","journal-title":"J Diabetes Sci Technol"},{"key":"4463_CR42","doi-asserted-by":"crossref","first-page":"502","DOI":"10.2337\/dc15-2035","volume":"39","author":"B Kovatchev","year":"2016","unstructured":"Kovatchev B, Cobelli C (2016) Glucose variability: timing, risk analysis, and relationship to hypoglycemia in diabetes. Diabetes Care 39:502\u2013510","journal-title":"Diabetes Care"},{"key":"4463_CR43","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1089\/dia.2013.0051","volume":"15","author":"RM Bergenstal","year":"2013","unstructured":"Bergenstal RM, Ahmann AJ, Bailey T et al (2013) Recommendations for standardizing glucose reporting and analysis to optimize clinical decision making in diabetes: the Ambulatory Glucose Profile (AGP). Diabetes Technol Ther 15:198\u2013211","journal-title":"Diabetes Technol Ther"},{"issue":"Suppl. 2","key":"4463_CR44","doi-asserted-by":"crossref","first-page":"S234","DOI":"10.1089\/dia.2015.0369","volume":"18","author":"J Pettus","year":"2016","unstructured":"Pettus J, Edelman SV (2016) Use of glucose rate of change arrows to adjust insulin therapy among individuals with type 1 diabetes who use continuous glucose monitoring. Diabetes Technol Ther 18(Suppl. 2):S234\u2013S242","journal-title":"Diabetes Technol Ther"},{"key":"4463_CR45","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1177\/1932296816639069","volume":"10","author":"J Pettus","year":"2016","unstructured":"Pettus J, Edelman SV (2016) Differences in use of glucose rate of change (ROC) arrows to adjust insulin therapy among individuals with type 1 and type 2 diabetes who use continuous glucose monitoring (CGM). J Diabetes Sci Technol 10:1087\u20131093","journal-title":"J Diabetes Sci Technol"},{"key":"4463_CR46","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1177\/1932296816661735","volume":"11","author":"B Gehr","year":"2017","unstructured":"Gehr B, Holder M, Kulzer B et al (2017) SPECTRUM: a training and treatment program for continuous glucose monitoring for all age groups. J Diabetes Sci Technol 11:284\u2013289","journal-title":"J Diabetes Sci Technol"},{"key":"4463_CR47","unstructured":"International Diabetes Center. Hybrid Closed Loop Insulin Delivery Webinar (Sessions 1 and 2), Professional Education Approved for AMA Physician Recognition Award Category 1 Credit. Available from \nhttps:\/\/livestream.com\/accounts\/5053468\/events\/7288221\n\n and \nhttps:\/\/livestream.com\/accounts\/5053468\/events\/7288256\n\n. Accessed 22 Sept 2017"},{"key":"4463_CR48","unstructured":"International Diabetes Center. AGP - Ambulatory Glucose Profile. Available from \nwww.agpreport.org\/agp\/agpreports\n\n. Accessed 27 Mar 2017"},{"key":"4463_CR49","unstructured":"Noridian Healthcare Solutions (2017) Coding and coverage - therapeutic continuous glucose monitors (CGM). Available from \nhttps:\/\/med.noridianmedicare.com\/web\/jadme\/policies\/dmd-articles\/coding-and-coverage-therapeutic-continuous-glucose-monitors\n\n. Accessed 25 Sept 2017"},{"issue":"Suppl. 2","key":"4463_CR50","first-page":"S2","volume":"18","author":"D Rodbard","year":"2016","unstructured":"Rodbard D (2016) Continuous glucose monitoring: a review of successes, challenges, and opportunities. Diabetes Technol Ther 18(Suppl. 2):S2\u2013S13","journal-title":"Diabetes Technol Ther"},{"key":"4463_CR51","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1177\/193229681200600631","volume":"6","author":"L Heinemann","year":"2012","unstructured":"Heinemann L, Franc S, Phillip M et al (2012) Reimbursement for continuous glucose monitoring: a European view. J Diabetes Sci Technol 6:1498\u20131502","journal-title":"J Diabetes Sci Technol"},{"key":"4463_CR52","doi-asserted-by":"crossref","first-page":"v","DOI":"10.3310\/hta20170","volume":"20","author":"R Riemsma","year":"2016","unstructured":"Riemsma R, Corro Ramos I, Birnie R et al (2016) Integrated sensor-augmented pump therapy systems [the MiniMed\u00ae Paradigm\u2122 Veo system and the Vibe\u2122 and G4\u00ae PLATINUM CGM (continuous glucose monitoring) system] for managing blood glucose levels in type 1 diabetes: a systematic review and economic evaluation. Health Technol Assess 20:v\u2013xxxi 1\u2013251","journal-title":"Health Technol Assess"},{"key":"4463_CR53","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1001\/jama.2016.1903","volume":"315","author":"JM Lee","year":"2016","unstructured":"Lee JM, Hirschfeld E, Wedding JA (2016) patient-designed do-it-yourself mobile technology system for diabetes: promise and challenges for a new era in medicine. JAMA 315:1447\u20131448","journal-title":"JAMA"},{"issue":"Suppl. 1","key":"4463_CR54","first-page":"A21","volume":"65","author":"K Nakamura","year":"2016","unstructured":"Nakamura K, Ebner E, Price DA (2016) Similar estimated A1c results reported between patients with diabetes using CGM whether on multiple daily injections (MDI) or continuous subcutaneous insulin infusion (CSII) (Abstract). Diabetes 65(Suppl. 1):A21","journal-title":"Diabetes"},{"key":"4463_CR55","unstructured":"Cottin VR, Gillis AM, Halligan D, Movsowitz CM (2012) Protect your practice: medico-legal considerations of remote monitoring. Available from \nwww.cardiovascularbusiness.com\/topics\/healthcare-economics\/protect-your-practice-medico-legal-considerations-remote-monitoring\n\n. Accessed 27 Mar 2017"},{"key":"4463_CR56","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1177\/1932296816647516","volume":"10","author":"DC Klonoff","year":"2016","unstructured":"Klonoff DC, Kleidermacher DN (2016) Now is the time for a cybersecurity standard for connected diabetes devices. J Diabetes Sci Technol 10:623\u2013626","journal-title":"J Diabetes Sci Technol"},{"key":"4463_CR57","unstructured":"European Commission (2016) EU Commission and United States agree on new framework for transatlantic data flows: EU-US Privacy Shield. Available from \nhttp:\/\/europa.eu\/rapid\/press-release_IP-16-216_en.htm\n\n. Accessed 27 Mar 2017"},{"key":"4463_CR58","first-page":"155","volume":"60","author":"International Hypoglycaemia Study Group","year":"2017","unstructured":"International Hypoglycaemia Study Group (2017) Glucose concentrations of less than 3.0 mmol\/l (54 mg\/dl) should be reported in clinical trials: a joint position statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetologia 60:155\u2013157","journal-title":"Diabetologia"},{"key":"4463_CR59","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.2337\/dc14-3053","volume":"38","author":"BA Buckingham","year":"2015","unstructured":"Buckingham BA, Raghinaru D, Cameron F et al (2015) Predictive low-glucose insulin suspension reduces duration of nocturnal hypoglycemia in children without increasing ketosis [published correction appears in Diabetes Care 2015;38:1813]. Diabetes Care 38:1197\u20131204","journal-title":"Diabetes Care"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00125-017-4463-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-017-4463-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-017-4463-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,11,3]],"date-time":"2017-11-03T15:46:54Z","timestamp":1509724014000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00125-017-4463-4"}},"subtitle":["A joint statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working Group"],"short-title":[],"issued":{"date-parts":[[2017,10,25]]},"references-count":59,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["4463"],"URL":"https:\/\/doi.org\/10.1007\/s00125-017-4463-4","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,25]]}}}